AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharmaceutical Companies

656.138

-6.217-0.94%

Number of Gainers:6

Number of Losers:17

Number of Flat:20

PE:- -

High:666.258

Open:660.539

Low:655.395

Close:662.355

Volume:61.41M

Turnover:116.52M

Market Cap:92.69B

Float Cap:89.39B

Loading ...

Invion Ltd-Ivx Credentialed International Biotech Leader Joins Board

THOMSON REUTERS

ASX Stocks Estimated To Be Trading Below Fair Value In August 2026

Simply Wall St.

Haemonetics Shares Rise After Signing Supply Agreement With CSL Plasma

MT Newswires Live

Asia Morning Call-Global Markets

Haemonetics Signs Non-Exclusive US Plasma Supply Deal with CSL Plasma for NexSys PCS Devices, Disposables

CSL (ASX:CSL) Shares Confront Profit Reversal As Recovery Case Stays Unproven

Simply Wall St.

Switzerland's Basilea H1 Revenue Rises on Cresemba Demand; Ups 2026 Profit Outlook

CSL's Fiscal 2026 Results In Line, Jefferies Says

MT Newswires Live

Csl FY Adjusted Net Income USD 3,100 Million

Shares of CSL Limited up 12.9% at A$152 in Early Trade After Annual Results

THOMSON REUTERS

CSL FY26 Underlying NPATA Falls 2% to Us$3.1 Billion; Reported Net Loss Widens to Us$2.6 Billion

CSL Final Dividend Us$1.62 Per Share

THOMSON REUTERS

CSL Limited - Announce a Further A$1.1 Billion Share Buy-Back Program

THOMSON REUTERS

CSL Limited - Recognised Pre-Tax Impairments of $5.5 Billion in 2H FY26

THOMSON REUTERS

CSL Limited Sees FY Underlying Npat Growth of Approximately 5%

THOMSON REUTERS

CSL Limited - Intention to Spend Approximately $1.5 Billion to Expand Its U.S. Plasma Manufacturing Presence

THOMSON REUTERS

CSL FY Adjusted Net Income USD 3,100 Million

THOMSON REUTERS

CSL Limited - CSL Seqirus Expects Low Single Digit Revenue Growth in FY

THOMSON REUTERS

ASX Insights Lynas Rare Earths And 2 Stocks That Might Be Priced Below Their Estimated Value

Simply Wall St.

3 ASX Dividend Stocks Paying Investors While They Wait

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/BK7508/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":656.13776,"timestamp":1788155999504,"preClose":662.35516,"halted":0,"volume":61408438,"delay":0,"changeRate":-0.009387,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Pre CSPA","change":-6.217407,"latestTime":"08-31 16:00:00 AEST","open":660.5389,"high":666.2579,"low":655.3953,"amount":116520727,"amplitude":0.0164,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788134400000,1788156000000]],"turnoverRate":0.002409,"increases":7,"decrements":17,"flats":19,"marketCap":92694912137.5,"floatMarketCap":89392893767.375},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":666.2579,"amplitude":0.0164,"preClose":662.35516,"low":655.3953,"latestPrice":656.13776,"volume":61408438,"delay":0,"open":660.5389,"prevYearClose":644.3692,"prevWeekClose":662.355,"prevMonthClose":488.077,"prevQuarterClose":464.145,"fiveDayClose":657.516,"twentyDayClose":493.047,"sixtyDayClose":409.453,"secType":"PLATE","market":"AU","turnoverRate":0.002409,"marketCap":92694912137.5,"floatMarketCap":89392893767.375,"timestamp":1788155999504,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":6,"down":17,"flat":20},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660490054","title":"Invion Ltd-Ivx Credentialed International Biotech Leader Joins Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2660490054","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660490054?lang=en_us&edition=fundamental","pubTime":"2026-08-19 07:22","pubTimestamp":1787095324,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nTUE3N4Y4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IVX.AU","BK7509","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660497250","title":"ASX Stocks Estimated To Be Trading Below Fair Value In August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660497250","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660497250?lang=en_us&edition=fundamental","pubTime":"2026-08-19 03:04","pubTimestamp":1787079872,"startTime":"0","endTime":"0","summary":"As the Australian market grapples with the implications of rising oil prices and their potential inflation impacts, investors are increasingly looking for opportunities within sectors that may be trading below their intrinsic value. In such a climate, identifying undervalued stocks can be particularly advantageous, as these investments often offer significant potential for growth when broader market conditions stabilize.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-pnv/polynovo-shares/news/asx-stocks-estimated-to-be-trading-below-fair-value-in-augus","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-pnv/polynovo-shares/news/asx-stocks-estimated-to-be-trading-below-fair-value-in-augus","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VOTE","BK7015","BK7503","FDV.AU","BK7055","SLC.AU","BK7007","BK4588","SPHQ","BK7104","NWH.AU","BK7126","MSB.AU","COH.AU","BK7508","BK7067","BK7062","NGI.AU","PNV.AU","NXL.AU","BK4585","SYL.AU","DECU","XRO.AU","BK7501","PMDE","BK7002","BK7016","GMD.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660149195","title":"Haemonetics Shares Rise After Signing Supply Agreement With CSL Plasma","url":"https://stock-news.laohu8.com/highlight/detail?id=2660149195","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660149195?lang=en_us&edition=fundamental","pubTime":"2026-08-19 02:40","pubTimestamp":1787078411,"startTime":"0","endTime":"0","summary":"Haemonetics  shares were up more than 17% in afternoon trading on Tuesday after the company said it entered into a supply agreement with CSL Plasma last week.The deal involves Haemonetics' NexSys PCS plasma collection system with Persona Plus Technology, an automated cell separator system, along with related disposables in the US, according to a Tuesday filing.CSL is expected to transition a portion of its US plasma collection centers to Haemonetics' devices and disposables, but the scope and timing of the implementation are still to be determined, the company said.Price: 105.99, Change: +15.72, Percent Change: +17.41","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B64QTZ34.USD","LU1169589451.USD","HAE","SG9999004303.SGD","IE0034390439.USD","IE00B19Z6F94.USD","SGXZ23171101.USD","CSL.AU","BK4198","BK4086","LU0205193047.USD","LU0012050646.USD","LU0205194284.USD","BK7501","BK7067","BK7511","BK7508","LU0728928796.USD","IE00BLDYK493.USD","CSL","LU1169590202.USD","LU0106261612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660916144","title":"Asia Morning Call-Global Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2660916144","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660916144?lang=en_us&edition=fundamental","pubTime":"2026-08-19 02:39","pubTimestamp":1787078393,"startTime":"0","endTime":"0","summary":"Asia Morning Call-Global MarketsAug 19 (Reuters)-Stock MarketsNet ChngStock MarketsNet ChngS&P/ASX 200**9070.00-3.20NZX 50**13866.18144.20DJIA53377.48-82.30NIKKEI**67460.73-1,759.52Nasdaq26316.48-327.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL4N44F14G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765059.SGD","BK4588","LU1267930730.SGD","FDIQ","LU0511384066.AUD","LU0289961442.SGD","CSL.AU","LU0708995401.HKD","LU0390134368.USD","LU1804176565.USD","BK4112","LU0109391861.USD","BK7508","LU2210149790.SGD","LU0175139822.USD","IE00BKPKM429.USD","LU2265009873.SGD","BK7511","LU0289739343.SGD","LU2210150020.SGD","BK7501","BK7067","LU2095319765.USD","LU1691799644.USD","LU0672654240.SGD","MSCI","BK4585","LU0289960550.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660466734","title":"Haemonetics Signs Non-Exclusive US Plasma Supply Deal with CSL Plasma for NexSys PCS Devices, Disposables","url":"https://stock-news.laohu8.com/highlight/detail?id=2660466734","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660466734?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:06","pubTimestamp":1787047565,"startTime":"0","endTime":"0","summary":"Haemonetics signs non-exclusive US plasma supply deal with CSL Plasma for NexSys PCS devices, disposablesHaemonetics signed a non-exclusive U.S. supply agreement with CSL Plasma on Aug. 14, 2026 for N","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDLpVv5B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7067","BK7511","LU0205193047.USD","BK7508","IE0034390439.USD","BK4198","HAE","LU0205194284.USD","LU1169590202.USD","IE00BLDYK493.USD","IE00B19Z6F94.USD","BK7501","LU0012050646.USD","IE00B64QTZ34.USD","LU0106261612.USD","LU1169589451.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660466219","title":"CSL (ASX:CSL) Shares Confront Profit Reversal As Recovery Case Stays Unproven","url":"https://stock-news.laohu8.com/highlight/detail?id=2660466219","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660466219?lang=en_us&edition=fundamental","pubTime":"2026-08-18 17:22","pubTimestamp":1787044958,"startTime":"0","endTime":"0","summary":"CSL stock went into this result having climbed over the past quarter, closing at A$157.82, yet the latest numbers land with a jolt. The global biotech giant posted a trailing twelve month loss from continuing operations of US$2.99b on revenue of US$15.80b. That kind of earnings squeeze grabs short term traders by the throat. For long term investors, the real question now is how to weigh that loss against analyst forecasts that point to a return to profitability, as well as the current gap...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-shares-confront-profit-reversal-as-recovery-case","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-asxcsl-shares-confront-profit-reversal-as-recovery-case","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","FEBU","JOYT","GXDW","VGFPF","BK7511","PMDE","SG9999004303.SGD","CSL.AU","LU0728928796.USD","BK4086","LU1169590202.USD","RGLO","SGXZ23171101.USD","BK7501","BK7508","CSL","LU1169589451.USD","VOTE","DECU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660454593","title":"Switzerland's Basilea H1 Revenue Rises on Cresemba Demand; Ups 2026 Profit Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2660454593","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660454593?lang=en_us&edition=fundamental","pubTime":"2026-08-18 13:26","pubTimestamp":1787030795,"startTime":"0","endTime":"0","summary":"Switzerland's Basilea H1 revenue rises on Cresemba demand; ups 2026 profit outlookOverviewSwitzerland biopharma firm's H1 2026 revenue grew 14% yr/yr to CHF 119 mlnOperating profit for H1 2026 rose 32","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL1N44F03R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7501","BK7508","BK1161","BK1230","LU2148510915.USD","BK7511","BK7067","LU1064131003.USD","LU1934453819.USD","00656","LU0196878994.USD","02696","HK0000306685.HKD","002422","BK0060","BK0239","HK0000306701.USD","HK0000320223.HKD","HK0000320264.USD","LU1064130708.USD","06990","LU1979443071.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660745574","title":"CSL's Fiscal 2026 Results In Line, Jefferies Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660745574","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660745574?lang=en_us&edition=fundamental","pubTime":"2026-08-18 10:00","pubTimestamp":1787018443,"startTime":"0","endTime":"0","summary":"CSL's  fiscal 2026 results are in line, and it guided for fiscal 2027 net profit after tax  growth of around 5%, Jefferies said in a Tuesday note.The firm's normalized fiscal 2026 net profit after tax and before amortization of $3.1 billion fell around 4% year-over-year and 2% in constant currency, compared with the brokerage's forecast of $3.09 billion.Its fiscal 2026 normalized earnings per share of $5.38 decreased around 3% on the year-ago period, compared with Jefferies' estimate of $5.76.Its fiscal 2027 revenue is expected by the firm to be in line with the prior year and underlying NPAT growth of around 5%, implying an underlying CSL fiscal 2027 NPAT of around $2.98 billion on a constant currency basis, compared with Jefferies' forecast of $2.8 billion on a non-constant currency basis.The investment firm assigned CSL a hold rating and a price target of AU$119 per share.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CSL.AU","BK4086","BK7067","LU1169590202.USD","SG9999004303.SGD","BK7501","LU0728928796.USD","LU1169589451.USD","SGXZ23171101.USD","BK7508","CSL","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660453908","title":"Csl FY Adjusted Net Income USD 3,100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660453908","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660453908?lang=en_us&edition=fundamental","pubTime":"2026-08-18 09:02","pubTimestamp":1787014965,"startTime":"0","endTime":"0","summary":"BRIEF-Csl FY Adjusted Net Income USD 3,100 MillionAug 18 -CSL LimitedCSL.AX:FY ADJUSTED NET INCOME USD 3,100 MILLIONSEES FY UNDERLYING NPAT GROWTH OF  APPROXIMATELY 5%DIVIDEND MAINTAINED; SHARE BUY-BACK  PROGRAM CONTINUEDCSL SEQIRUS EXPECTS LOW SINGLE DIGIT REVENUE GROWTH IN FYSEES FY27 REVENUE TO BE IN LINE WITH THE PRIOR YEAR AND UNDERLYING NPAT GROWTH OF APPROXIMATELY 5%CSL BEHRING EXPECTS MID-SINGLE DIGIT REVENUE GROWTH IN FYANNOUNCE A FURTHER  A$1.1 BILLION SHARE BUY-BACK PROGRAMRECOGNISED PRE-TAX IMPAIRMENTS OF $5.5 BILLION IN 2H FY26INTENTION TO SPEND APPROXIMATELY $1.5 BILLION TO EXPAND ITS U.S. PLASMA  MANUFACTURING PRESENCEFurther company coverage:CSL.AX","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nPLXMQ2BQ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","CSL.AU","BK7511","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660458382","title":"Shares of CSL Limited up 12.9% at A$152 in Early Trade After Annual Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660458382","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660458382?lang=en_us&edition=fundamental","pubTime":"2026-08-18 08:02","pubTimestamp":1787011343,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44E0WX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","CSL.AU","BK7067","BK7511","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660437278","title":"CSL FY26 Underlying NPATA Falls 2% to Us$3.1 Billion; Reported Net Loss Widens to Us$2.6 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2660437278","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660437278?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:14","pubTimestamp":1787004898,"startTime":"0","endTime":"0","summary":"CSL FY26 underlying NPATA falls 2% to US$3.1 billion; reported net loss widens to US$2.6 billionCSL posted a net loss after tax of US$2.6 billion, swinging from profit, on one-off restructuring costs,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL2bJkFB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7511","BK7501","CSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660371724","title":"CSL Final Dividend Us$1.62 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2660371724","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660371724?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:00","pubTimestamp":1787004013,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLX31HNDN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7508","BK7067","BK7501","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660437484","title":"CSL Limited - Announce a Further A$1.1 Billion Share Buy-Back Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2660437484","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660437484?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:00","pubTimestamp":1787004010,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXMQ2BQ8:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","CSL.AU","BK7511","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660437482","title":"CSL Limited - Recognised Pre-Tax Impairments of $5.5 Billion in 2H FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2660437482","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660437482?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:00","pubTimestamp":1787004010,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXMQ2BQ8:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7501","BK7067","BK7508","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660437178","title":"CSL Limited Sees FY Underlying Npat Growth of Approximately 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660437178","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660437178?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:00","pubTimestamp":1787004010,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXMQ2BQ8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7067","BK7501","CSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660374874","title":"CSL Limited - Intention to Spend Approximately $1.5 Billion to Expand Its U.S. Plasma Manufacturing Presence","url":"https://stock-news.laohu8.com/highlight/detail?id=2660374874","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660374874?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:00","pubTimestamp":1787004010,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXMQ2BQ8:9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","CSL.AU","BK7511","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660371084","title":"CSL FY Adjusted Net Income USD 3,100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660371084","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660371084?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:00","pubTimestamp":1787004010,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXMQ2BQ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7508","BK7501","CSL.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660176437","title":"CSL Limited - CSL Seqirus Expects Low Single Digit Revenue Growth in FY","url":"https://stock-news.laohu8.com/highlight/detail?id=2660176437","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660176437?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:00","pubTimestamp":1787004010,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXMQ2BQ8:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","BK7501","CSL.AU","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660489437","title":"ASX Insights Lynas Rare Earths And 2 Stocks That Might Be Priced Below Their Estimated Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2660489437","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660489437?lang=en_us&edition=fundamental","pubTime":"2026-08-18 03:04","pubTimestamp":1786993475,"startTime":"0","endTime":"0","summary":"As the S&P/ASX 200 index faces a projected dip following last week's decline, investors are keenly observing market movements amidst global economic shifts and fluctuating commodities prices. In this climate, identifying stocks that may be undervalued can present opportunities for investors seeking potential value, with companies like Lynas Rare Earths possibly offering such prospects.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-vau/vault-minerals-shares/news/asx-insights-lynas-rare-earths-and-2-stocks-that-might-be-pr","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-vau/vault-minerals-shares/news/asx-insights-lynas-rare-earths-and-2-stocks-that-might-be-pr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SETM","GMD.AU","BK7126","BK7503","ARX.AU","BK7095","BK4588","LYC.AU","XRO.AU","BK7055","PNV.AU","BK7062","FDV.AU","BK7508","BK7002","BK7067","NGI.AU","BK7015","SXE.AU","MSB.AU","BK7507","NXL.AU","VAU.AU","BK7016","NWH.AU","BK7104","SPHQ","BK7501","BK4585","SLC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431738","title":"3 ASX Dividend Stocks Paying Investors While They Wait","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431738","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660431738?lang=en_us&edition=fundamental","pubTime":"2026-08-18 01:19","pubTimestamp":1786987170,"startTime":"0","endTime":"0","summary":"With central banks keeping policy paths in sharp focus and 10Y bond yields edging higher, income investors are being asked to work harder for dependable cash flow. That is where Dividend Powerhouses with 5%+ yields and solid coverage come into play, offering income potential while capital is deployed. These stocks are designed to pay you while you wait. This article walks through three standouts from the screener and explains what makes each one worth a closer look.\nThe three stocks below are...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-asx-dividend-stocks-paying-investors-while-they-wait","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-asx-dividend-stocks-paying-investors-while-they-wait","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","BK7511","BK7508","GXDW","FEBU","CBA.AU","BK7135","VGFPF","RGLO","BK7067","DECU","CSL.AU","PMDE","BK4585","VOTE","QTOC","CPU.AU","BK7503","BK7157","BK4588","BK4211","VIG","BK7033","BK7501","JOYT","SPHQ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":7,"totalSize":148,"code":"91000000","status":"200"}]}}